Statistics Act, 1999
R 385
Prevention of and Treatment for Substance Abuse Act, 2008 (Act No. 70 of 2008)RulesRules Governing the Quorum, Procedure at meetings and, generally the Conduct of Functions of the Central Drug Authority12. Roles and responsibilities of Portfolio Committees of Central Drug Authority |
| (1) | The Governance Committee shall— |
| (a) | Annually compile the CDA Annual Report for recommendation by the CDA and submission to the Minister of Social Development for approval |
| (b) | Provide oversight of risk management and ensuring that risk controls are effective for the CDA. |
| (c) | Recommend to the CDA, the review of the National Drug Master Plan every five years. |
| (d) | Advise the CDA on the review of policy or legislation or development of new legislation to respond to the challenges of the supply of, demand and treatment for drugs and substances of abuse, as well as the policies governing the CDA and its structures. |
| (e) | Serve as custodian of good governance of the CDA. |
| (f) | Facilitate the empowerment, training, and capacity building of the CDA members, it's committees and the Secretariat. |
| (g) | Oversee the effective functioning of all the structures of the CDA, including PSAF and LDACs. |
| (h) | Ensure the participation of all relevant departments, agencies, NGO's both local and international in the work of the CDA in line with the Act No. 70 of 2008 or as determined by need towards the achievement of the goals of the CDA. |
| (i) | Ensure compliance with statutory prescripts and international obligations that the country has ratified/acceded to. |
| (j) | Facilitate submission of reports of the CDA and its substructures. |
| (k) | Monitor and accelerate functioning of the Secretariat and general administrative support to the CDA. |
| (2) | Project and Programme Committee, which shall— |
| (a) | Develop annual plans for programmes and projects to further the goals of the NDMP |
| (b) | Assume overall responsibility for the business issues associated with projects and programmes that are essential to ensure the delivery of the project outputs and the attainment of project outcomes, in line with the strategic plan of the CDA and the goals of the NDMP |
| (c) | Monitor, on an ongoing basis, the quality and impact of all projects as they develop. |
| (d) | Provide advice about changes to projects and programmes developed. |
| (e) | Provide support, guidance, and oversight on all projects and programmes. |
| (f) | Provide an annual report of the CDA projects and programme activities to the CDA Executive Committee and CDA at the end of each financial year, for incorporation into the CDA annual report. |
| (3) | Research, Development, Monitoring and Evaluation Committee, which shall— |
| (a) | provide oversight and strategies to the CDA on research priorities, and the development of collaborative and strategic research programmes, with particular reference to opportunities arising out of the national research agenda and CDA roles and responsibilities as defined in the Act and the NDMP; |
| (b) | seek opportunities for the CDA to enhance research programmes in conjunction with external agencies, including the private sector, non-governmental organizations, institutions of higher learning and other government aligned and funded research agencies; |
| (c) | seek opportunities at national and international level to leverage the expertise and capacity to advance the resourcing (including government funding) of substance abuse research, including intervention strategies and their effectiveness; |
| (d) | set and monitor key research performance indicators for the CDA |
| (e) | monitor trends on substance use and abuse research, and related fields being undertaken and to identify and make recommendations on the most appropriate areas for research. |
| (f) | be a repository of all national and international research on substance abuse, disseminate the latest research information to CDA structures and maintain a resource library (National Clearing House) of publications produced by the CDA and its local and international partners. |
| (g) | provide an annual report on research, development , monitoring and evaluation activities, at the end of each financial year, for incorporation into the annual report of the CDA. |
| (4) | Communication and Marketing Committee, which shall— |
| (a) | Develop and implement the CDA strategic communications and marketing plans to promote the CDA's vision, mission, values, and goals of the NDMP. |
| (b) | Manage public relations and advance the CDA's internal and external communications affairs. |
| (c) | Advise on the creation of messages that raise awareness and educate the country on substance abuse related matters. |
| (d) | Ensure visibility of the CDA in multiple formats and forums. |
| (e) | The Committee is responsible for the following activities: |
| (i) | Develop and maintain a CDA Website. |
| (ii) | Establish, maintain, and market social media forms of communication (Twitter feed, WhatsApp, and Facebook page) on substance abuse and publications. |
| (iii) | Manage communications in respect of the Clearing House. |
| (iv) | Coordinate CDA annual public activities and provide progress report. |
| (v) | Oversee CDA branding, including reviews as and when necessary. |
| (vi) | Collaborate with and advice the CDA, on matters related to communications. |
| (5) | Finance, Social and Ethics Committee, which shall— |
| (a) | facilitate the development of a Social and Ethics Policy for the CDA; |
| (b) | assess and review the adequacy and effectiveness of the CDA's engagement and interaction with its stakeholders at all levels; |
| (c) | develop and oversee adherence to the ethical standards (Code of Conduct) of the CDA, and ensure that the CDA takes measures to integrate and achieve adherence to these standards in all aspects of the business of the CDA, thus facilitating a sustainable ethical corporate culture; |
| (d) | minimizing ethical risks in the CDA and its role-players, and access opportunities to create awareness around ethical practice within the ambit of the CDA's core mandate; |
| (e) | maintaining and building ethical awareness through training programmes on the policy, including the management of ethical dilemmas inherent in the work of the CDA; |
| (f) | monitoring that all structures of the CDA and its partners, implement programmes, guidelines and practices are congruent with the CDA's social and ethics policy; |
| (g) | protect the interests of all role-players including vulnerable individuals, groups, families and communities in the process of implementing the National Drug Master Plan's mandate and objectives, i.e., the CDA's NDMP-related ethical responsibility and ensure that the CDA and all stakeholders adhere to the principles of the NDMP; |
| (h) | review the CDA's corporate governance from an ethical perspective in cooperation with the Governance Committee, in line with the core mandate of the NDMP; |
| (i) | periodically review the performance of the CDA in implementing the provisions of the code of ethics, and adhering to the policy,which must then be consolidated into an Annual Report. |
| (j) | Ensure adequate resourcing of the CDA and its substructures in the performance of their functions; |
| (k) | Facilitate the rationalisation of existing resources and monitor their effective use; and |
| (I) | Ensure the adequate resourcing of the CDA, present the CDA MTEF budget to the CDA during the budget planning processes of the Department of Social Development and ensure that the budget and resources of the CDA are used efficiently, effectively, and economically. |
